Literature DB >> 35241375

Comment on: The APB study: apixaban pharmacokinetics in bariatric patients before to 1 year after vertical sleeve gastrectomy or Roux-en-Y gastric bypass.

Jacqueline A Murtha1, David A Harris2, Luke M Funk2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35241375      PMCID： PMC9275780          DOI： 10.1016/j.soard.2022.01.016

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN： 1550-7289            Impact factor:   3.709


× No keyword cloud information.
  4 in total

1.  The effect of bariatric surgery on the direct oral anticoagulant rivaroxaban: the extension study.

Authors:  Dino Kröll; Philipp C Nett; Yves Michael Borbély; Sabine Schädelin; Debora Bertaggia Calderara; Lorenzo Alberio; Guido Stirnimann
Journal:  Surg Obes Relat Dis       Date:  2018-09-19       Impact factor: 4.734

Review 2.  Pharmacokinetic changes post-bariatric surgery: A scoping review.

Authors:  Liam A McLachlan; Betty B Chaar; Irene S Um
Journal:  Obes Rev       Date:  2020-02-25       Impact factor: 9.213

3.  Bariatric Surgery Outcomes in Patients on Preoperative Therapeutic Anticoagulation: an Analysis of the 2015 to 2017 MBSAQIP.

Authors:  Aryan Modasi; Jerry T Dang; Sadaf Afraz; Joshua Hefler; Noah Switzer; Daniel W Birch; Shahzeer Karmali
Journal:  Obes Surg       Date:  2019-11       Impact factor: 4.129

Review 4.  Use of Direct Oral Anticoagulants in Morbidly Obese Patients.

Authors:  Kazuhiko Kido; James C Lee; Thaddaus Hellwig; Michael P Gulseth
Journal:  Pharmacotherapy       Date:  2019-12-30       Impact factor: 4.705
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.